2008
DOI: 10.1016/j.ejpb.2008.03.006
|View full text |Cite
|
Sign up to set email alerts
|

Reversible protein precipitation to ensure stability during encapsulation within PLGA microspheres

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
60
0
1

Year Published

2009
2009
2017
2017

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 85 publications
(63 citation statements)
references
References 43 publications
2
60
0
1
Order By: Relevance
“…Alternatively, the s/o/w procedure has also been proposed, predominantly for hydrophilic proteins. 30 Using these approaches, drug entrapment levels observed in this study broadly agreed with the results of previous studies. 12 However, to increase entrapment efficiency, we examined the effect of altering the pH of the external aqueous phase.…”
Section: Discussionsupporting
confidence: 82%
“…Alternatively, the s/o/w procedure has also been proposed, predominantly for hydrophilic proteins. 30 Using these approaches, drug entrapment levels observed in this study broadly agreed with the results of previous studies. 12 However, to increase entrapment efficiency, we examined the effect of altering the pH of the external aqueous phase.…”
Section: Discussionsupporting
confidence: 82%
“…The higher M W polymer, PGA-co-PDL (1:1:1, 39.0 KDa), and the more hydrophobic polymers, PGA-co-PDL (1:1:1.45) and PPA-co-PDL, showed a significantly (p50.05) higher bioactive fraction, after 5 and 24 h release, compared to the other co-polymers. The maximum LS bioactive fraction was found using PGA-co-PDL LS is a relatively stable enzyme 55 which can better withstand the harsh condition of the emulsification process and this was confirmed by the retention of its bioactivity at zero time of release (bioactive fraction ranged from 0.9 to 1.03 for all the investigated polymers, Figure 7). Similarly, it was reported by Giteau and coworkers that the LS released from PLGA microspheres was still biologically active compared to a-CH, peroxidase and b-galactosidase-loaded PLGA microspheres 57…”
Section: Enzyme Bioactivitymentioning
confidence: 74%
“…Although lysozyme has sometimes been referred to be a relatively stable protein, its low recovery in the presence of PLGA was remarkable (3,8). The low recovery of lysozyme as well as its incomplete release from PLGA-based delivery systems has been related to the protein instability during manufacturing of the delivery system and during release (2,4,9).…”
Section: Introductionmentioning
confidence: 99%
“…Lysozyme is a popular model protein in pharmaceutical research, and its incorporation into PLGA-based delivery systems has been reported extensively (2)(3)(4)(5)(6)(7). Although lysozyme has sometimes been referred to be a relatively stable protein, its low recovery in the presence of PLGA was remarkable (3,8).…”
Section: Introductionmentioning
confidence: 99%